Medico Intercontinental Fair Value
Medico Intercontinental fair value. Medico Intercontinental (MIL) average fair value is ₹1637.05 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹25.19 (+6398.81%), fair value range ₹32.0–₹6384.55. Explore MIL Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
MIL Fair Value vs Current Price — Valuation Summary
MIL average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Check Medico Intercontinental marketcap in USD to track the company's total market size over time.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
MIL Fair Value Analysis — Data Sources & Coverage
Medico Intercontinental financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit MIL share price.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
MIL vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Medico Intercontinental P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Viksit Engineering | VIKSHEN | - | - | - |
| Real Growth Corporation | RGCORP | - | - | - |
| Pulsar International | PULSRIN | -38.0 | 0.34 | ₹17 |
| Yarn Syndicate | YARNPP | - | 0.12 | ₹3 |
| Dhanlaxmi Cotex | DHANCOT | 287.23 | 0.95 | ₹63 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.